Journal
REVIEWS IN CARDIOVASCULAR MEDICINE
Volume 21, Issue 2, Pages 289-295Publisher
IMR PRESS
DOI: 10.31083/j.rcm.2020.02.92
Keywords
COVID-19; acute coronary syndrome; ST-elevation myocardial infarction; thrombolysis
Categories
Ask authors/readers for more resources
Consideration of thrombolysis as first-line reperfusion therapy in patients with COVID-19 and STEMI is recommended by ACC/SCAI guidelines. We describe a patient with COVID-19, who presented with ST-elevation myocardial infarction and was treated with thrombolysis and anticoagulation. He was later found to have a significant persistent thrombus burden requiring thrombectomy and stent placement. Invasive hemodynamics on multiple high-dose pressers revealed a high cardiac output state with low systemic vascular resistance, consistent with distributive rather than cardiogenic shock. Our case illustrates that thrombolytic therapy alone may not be adequate in patients with STEMI and COVID-19, as well as the importance of early invasive hemodynamics in management of shock in patient with STEMI and COVID-19 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available